ArticleJournal of arrhythmia2025
Sex based disparities in hospitalization and readmission outcomes for complete atrioventricular block: Insights from United States readmission data.
Article in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trends, Prevalence of Bradyarrhythmia and Pacemaker Implantation in Patients with Parkinson's Disease.Journal of cardiovascular development and disease · 2025Article
- Sex based disparities in hospitalization and readmission outcomes for complete atrioventricular block: Insights from United States readmission data.Journal of arrhythmia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sex disparities in cardiovascular disorders are well-documented, but data on hospitalization and readmission outcomes in the context of sex for Complete Heart Block (CHB) remains limited. Methods: We analyzed the 2016-2020 Nationwide Readmission Database to identify patients with a principal diagnosis of CHB. Men served as the control group, while women comprised the study cohort. The primary outcome was mortality. Secondary outcomes included odds of cardiac arrest, ventricular tachycardia, heart failure, mechanical ventilation use, all-cause 30-day readmission, total and early pacemaker use, length of stay (LOS), and total hospitalization charges (THC). Multivariate regression models adjusted for confounders. Results: Among 175,257 patients with CHB, 45% were female. Female sex was associated with higher odds of mortality (adjusted OR [aOR] 1.42, 95% CI 1.3-1.55) compared to males. Additionally, females had higher odds of cardiac arrest (aOR 1.13, 95% CI 1.06-1.2), ventricular tachycardia (aOR 1.1, 95% CI 1.05-1.17), heart failure (aOR 1.18, 95% CI 1.14-1.22), mechanical ventilation use (aOR 1.1, 95% CI 1.03-1.17), and all-cause 30-day readmission (aOR 1.1, 95% CI 1.03-1.14). Women also had lower odds of total pacemaker use (aOR 0.92, 95% CI 0.88-0.96) and early pacemaker use (aOR 0.89, 95% CI 0.86-0.82). Female patients exhibited longer LOS (4.13 days vs. 3.86 days, Conclusion: Female sex in CHB patients was associated with higher mortality and adverse events but lower pacemaker use compared to male patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.